Concepedia

Özge Saatci

ÖS

23

Publications

1.3K

Citations

19

H-Index

2016

Active since

Affiliations

University of South Carolina(Current)

Bilkent University

Medical University of South Carolina

Hacettepe University

MUSC Hollings Cancer Center

Özge Saatci is an author at University of South Carolina specializing in tumor biology, medicine, and cell biology.

ORCID

Top concepts

Publications per year

2016–2024

23

Publications

23

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer

Özge Saatci, Aysegül Kaymak, Umar Raza et al. · Nature Communications · 2020 · 346 citations · Full text

Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells

Annemarie Schwab, Aarif Siddiqui, Maria Eleni Vazakidou et al. · Cancer Research · 2018 · 125 citations · Full text

Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer

Özge Saatci, Simone Borgoni, Özge Akbulut et al. · Oncogene · 2018 · 80 citations · Full text

, , +12

miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer

Merve Mutlu, Özge Saatci, Suhail A. Ansari et al. · Scientific Reports · 2016 · 74 citations · Full text

The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer

Umar Raza, Özge Saatci, Stefan Uhlmann et al. · Oncotarget · 2016 · 58 citations · Full text

, , +14

Rows per page

1–5 of 23